These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26229958)

  • 1. Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels.
    Su FC; Li XD; Sun SX; Shi MY; Xue FH; Teng SC; Jiang L; Zhu J; Yin F; Gu HY
    Biomed Res Int; 2015; 2015():402481. PubMed ID: 26229958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Atorvastatin on Serum Levels of Total Cholesterol and High-Sensitivity C-reactive Protein in High-Risk Patients with Atrial Fibrillation in Asia.
    Shi MY; Xue FH; Teng SC; Jiang L; Zhu J; Yin F; Gu HY
    Clin Ther; 2015 Aug; 37(8):1740-50. PubMed ID: 26159841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Atorvastatin on Serum High-Sensitive C-Reactive Protein and Total Cholesterol Levels in Asian Patients With Atrial Fibrillation.
    Wang J; Wang AR; Zhang MJ; Li Y
    Am J Ther; 2017; 24(1):e20-e29. PubMed ID: 26566148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
    Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
    Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation.
    Lin YJ; Tsao HM; Chang SL; Lo LW; Tuan TC; Hu YF; Udyavar AR; Tsai WC; Chang CJ; Tai CT; Lee PC; Suenari K; Huang SY; Nguyen HT; Chen SA
    Am J Cardiol; 2010 Feb; 105(4):495-501. PubMed ID: 20152244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.
    Höglund N; Andersson J; Almroth H; Tornvall P; Englund A; Rosenqvist M; Jensen SM; Boman K
    Int J Cardiol; 2013 Sep; 167(5):2088-91. PubMed ID: 22704860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
    Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
    J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
    Patti G; Chello M; Candura D; Pasceri V; D'Ambrosio A; Covino E; Di Sciascio G
    Circulation; 2006 Oct; 114(14):1455-61. PubMed ID: 17000910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy decreased the recurrence frequency of atrial fibrillation after electrical cardioversion: a meta-analysis.
    Yan P; Dong P; Li Z; Cheng J
    Med Sci Monit; 2014 Dec; 20():2753-8. PubMed ID: 25529758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers according to types of atrial fibrillation.
    Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
    Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of High-sensitive C-reactive Protein and P-wave Dispersion in Lone Atrial Fibrillation.
    Zheng LH; Yao Y; Wu LM; Zhang KJ; Zhang S
    Chin Med J (Engl); 2015 Jun; 128(11):1450-4. PubMed ID: 26021499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Nortamo S; Ukkola O; Lepojärvi S; Kenttä T; Kiviniemi A; Junttila J; Huikuri H; Perkiömäki J
    Int J Cardiol; 2017 Dec; 248():173-178. PubMed ID: 28942872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).
    Negi S; Shukrullah I; Veledar E; Bloom HL; Jones DP; Dudley SC
    J Cardiovasc Electrophysiol; 2011 Apr; 22(4):414-9. PubMed ID: 20946227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis.
    Yo CH; Lee SH; Chang SS; Lee MC; Lee CC
    BMJ Open; 2014 Feb; 4(2):e004418. PubMed ID: 24556243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
    Ozaydin M; Varol E; Aslan SM; Kucuktepe Z; Dogan A; Ozturk M; Altinbas A
    Am J Cardiol; 2006 May; 97(10):1490-3. PubMed ID: 16679090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.